Tudor Investment Corporation »

Humacyte shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $274k 157k 1.74
2024-06-30 $58k 12k 4.80

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Spdr S&P 500 Etf Trust - US ETP ETF Option Call Option (SPY)
Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Nvidia Corp - US Equity (NVDA)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Unitedhealth Group Inc - US Equity (UNH)
Utilities Select Sector Spdr Fund - US ETP ETF Option Call Option (XLU)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Palantir Technologies Inc - US Equity (PLTR)
Oracle Corp - US Equity Option Call Option (ORCL)
Micron Technology Inc - US Equity (MU)
Goldman Sachs Group Inc/The - US Equity Option Call Option (GS)
Apple Inc - US Equity (AAPL)

View all positions for Tudor Investment Corporation

Top funds holding Humacyte

BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
UBS Group
Woodline Partners
Susquehanna International
Morgan Stanley
Two Sigma Investments
Millennium Management
Citadel Advisors
Northern Trust
Private Advisor
Charles Schwab Investment Management
Marshall Wace

View all funds holding Humacyte